BioMarin to Attend Upcoming Investor Conferences
04. Februar 2015 08:00 ET
|
BioMarin Pharmaceutical Inc.
- Leerink Global Healthcare Conference on February 12
- SunTrust Robinson Humphrey Orphan Drug Day on February 23
- Cowen and Company Annual Healthcare Conference March 3
SAN RAFAEL,...
BioMarin to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Wednesday, February 25 at 4:30pm ET
03. Februar 2015 08:00 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a...
BioMarin Announces Final Results of Tender Offer for Prosensa's Shares and Completion of Subsequent Offering Period
30. Januar 2015 08:00 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today the final results of, and the completion of the subsequent offering period relating to,...
BioMarin Announces Underwriters' Full Exercise of Option to Purchase Additional Shares
23. Januar 2015 08:00 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Jan. 23, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that the underwriters for its recently announced public offering of 8,500,000 shares of...
BioMarin Announces Pricing of Public Offering of Common Stock
22. Januar 2015 00:40 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today the pricing of an underwritten public offering of 8,500,000 shares of its common stock...
BioMarin Announces Public Offering of Common Stock
21. Januar 2015 16:01 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Jan. 21, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today an offering, subject to market and other conditions, of 7,250,000 shares of its common...
BioMarin Announces Completion of Tender Offer for Prosensa's Shares and Commences Subsequent Offering Period
15. Januar 2015 08:00 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Jan. 15, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that it completed the initial offering period for the previously announced tender offer...
BioMarin Provides Preliminary Data From Ongoing Phase 1/2 Pivotal Study of BMN 190 for Treatment of CLN2 Disorder, a Form of Batten Disease
12. Januar 2015 13:45 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced interim results from its Phase 1/2 pivotal study for BMN 190 or cerliponase alfa, a...
BioMarin Announces Planned Changes to Board of Directors Leadership Structure
07. Januar 2015 16:15 ET
|
BioMarin Pharmaceutical Inc.
- Jean-Jacques Bienaimé to Assume the Role of Chairman
- Richard Meier to Assume the Role of Lead Independent Director
SAN RAFAEL, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- BioMarin...
BioMarin to Present at the J.P. Morgan Healthcare Conference
06. Januar 2015 08:00 ET
|
BioMarin Pharmaceutical Inc.
SAN RAFAEL, Calif., Jan. 6, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), today announced that Jean-Jacques Bienaimé, Chief Executive Officer at BioMarin, will present a...